Journal article

Combination therapies to inhibit the RAF/MEK/ERK pathway in melanoma: We are not done yet

GA McArthur

Frontiers in Oncology | FRONTIERS MEDIA SA | Published : 2015

DOI: 10.3389/fonc.2015.00161

Download PDF

University of Melbourne Researchers

Grants

Citation metrics

30Scopus
26Web of Science
28Dimensions

Keywords

Bim
Science & Technology
Apoptosis
Life Sciences & Biomedicine
Oncology
Braf
Melanoma
32 Biomedical and Clinical Sciences
Metastatic Melanoma
Cdk4
Vemurafenib
Acquired-Resistance
Erk
Improved Survival
Cells
Braf-Mutant Melanoma
3202 Clinical Sciences
Raf Inhibition
Mek Inhibition
Mek
Kinase
3211 Oncology and Carcinogenesis
Reactivation